Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Apr 28, 2008; 14(16): 2561-2565
Published online Apr 28, 2008. doi: 10.3748/wjg.14.2561
Published online Apr 28, 2008. doi: 10.3748/wjg.14.2561
Table 1 Demographic and clinical data of the study patients (n = 100)
Parameter | No erythromycin | Erythromycin | P |
(n = 50) | (n = 50) | ||
Age, yr (mean ± SD) | 51.7 ± 21.6 | 52.1 ± 19.4 | 0.931 |
Male/Female | 32/18 | 36/14 | 0.39 |
Indications | 0.40 | ||
Suspected Crohn’s | 19 | 18 | 0.84 |
Obscure GI bleeding | 23 | 28 | 0.32 |
Others2 | 8 | 4 | 0.22 |
Final diagnosis in SB | 0.10 | ||
Normal findings | 23 | 19 | 0.42 |
Non-specific findings | 9 | 7 | 0.59 |
Crohn’s disease | 1 | 7 | 0.06 |
Angiodysplasia | 7 | 2 | 0.16 |
Polyps | 1 | 3 | 0.62 |
Others2 | 9 | 12 | 0.46 |
Table 2 Transit times, bile and cleanliness scores in the two study groups (mean ± SD)
No erythromycin | Erythromycin | P | |
(n = 50) | (n = 50) | ||
Gastric transit time (min) | 28.36 ± 23.56 | 21.08 ± 15.13 | 0.071 |
0.16 | |||
SB transit time (min) | 270.42 ± 108.13 | 279.14 ± 103.89 | 0.83 |
Total transit time (min) | 299.26 ± 108.18 | 300.22 ± 103.25 | 0.97 |
Did not reach the cecum (%) | 8 (16%) | 5 (10%) | 0.37 |
Bile presence score | 1.75 ± 0.61 | 1.76 ± 0.58 | 0.99 |
Cleanliness score | |||
Proximal SB | 1.78 ± 0.76 | 1.77 ± 0.74 | 1.00 |
Middle SB | 2.22 ± 0.75 | 2.16 ± 0.77 | 0.73 |
Distal SB | 2.79 ± 0.65 | 2.75 ± 0.74 | 0.73 |
Table 3 Gastric transit time with respect to cecum reachability
No erythromycin | Erythromycin | P | |
(n = 50) | (n = 50) | value | |
Gastric transit time in cases failing to reach cecum (min) | 36.75 ± 33.93 (n = 8) | 22.2 ± 14.45 (n = 5) | 0.52 |
Gastric transit time in cases where cecum was reached (min) | 26.76 ± 21.22 (n = 42) | 20.96 ± 15.36 (n = 45) | 0.24 |
P | 0.52 | 0.81 |
Table 4 Transit times according to indication for capsule endoscopy in Crohn’s disease and obscure gastrointestinal bleeding (OGIB)
Transit time | Indication | No erythromycin | Erythromycin | P |
(n = 50) | (n = 50) | |||
Gastric transit time (min) | Crohn’s disease | 27.16 ± 26.11 | 16.72 ± 13.21 | 0.19 |
OGIB | 29.82 ± 23.53 | 23.61 ± 16.49 | 0.43 | |
P | 0.41 | 0.16 | ||
Small bowel transit time (min) | Crohn's disease | 285.53 ± 96.31 | 324.50 ± 114.57 | 0.28 |
OGIB | 230.39 ± 103.00 | 255.32 ± 90.81 | 0.44 | |
P | 0.066 | 0.04 |
- Citation: Niv E, Bogner I, Barkay O, Halpern Z, Mahajna E, Depsames R, Kopelman Y, Fireman Z. Effect of erythromycin on image quality and transit time of capsule endoscopy: A two-center study. World J Gastroenterol 2008; 14(16): 2561-2565
- URL: https://www.wjgnet.com/1007-9327/full/v14/i16/2561.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.2561